Shire pays $56.5M in Adderall marketing whistleblower case

Shire pays $56.5M in Adderall marketing whistleblower case

How To Get Your Free Initial Consultation

To start an evaluation of your case, please complete the form below. The more information you can provide, the better able we will be to determine if we can help you.

We will review the information and let you know by email shortly if we may be able to handle your matter and what the next steps may be.

*This web site is designed for general information only. The information presented at this site should not be construed to be formal legal advice nor the formation of a lawyer/client relationship.

Shire Pharmaceuticals has agreed to pay the government more than $56 million to settle allegations by a whistleblower that it wrongly marketed several drugs, including Adderall, the popular treatment for attention deficit hyperactivity disorder.

The $56.5 million settlement stems for claims by a former Shire executive, Dr. Gerardo Torres, who alleged under the federal False Claims Act that the company marketed Adderall XR and other ADHD drugs as effective in ways that were not supported by clinical data.

According to the whistleblower lawsuit, Shire suggested Adderall XR would help counter certain ADHD related issues such as poor academic performance, criminal behavior and sexually transmitted diseases.

The settlement also covers allegations involving Shire's other ADHD drugs Vyvanse and Daytrana, and Pentasa and Lialda, which are approved for the treatment of ulcerative colitis.

The settlement calls for Shire, which has its U.S. headquarters in Wayne, Pa., to pay $35.7 million to the federal government. From that, Torres will receive $5.9 million. Additionally, the company will pay $20.8 million to the Medicaid-participating states.

Ross Feller Casey is a Philadelphia law firm with a national reputation for winning major qui tam lawsuits, including those involving leading pharmaceutical companies.

If you or someone you know has information about government fraud, you should contact our dedicated team of whistleblower lawyers immediately.

Your ability to file a successful whistleblower lawsuit could be limited, so the time to act is now. To learn more, go to

Disclaimer: Ross Feller Casey, LLP provides legal advice only after an attorney-client relationship is formed. Our website is an introduction to the firm and does not create a relationship between our attorneys and clients. An attorney-client relationship is formed only after a written agreement is signed by the client and the firm. Because every case is unique, the description of awards and summary of cases successfully handled are not intended to imply or guarantee that same success in other cases. Ross Feller Casey, LLP represents catastrophically injured persons and their families in injury and wrongful death cases, providing legal representation in Pennsylvania and New Jersey.